Search filters

List of works by Fabio Pastorino

A novel liposomal Clodronate depletes tumor-associated macrophages in primary and metastatic melanoma: Anti-angiogenic and anti-tumor effects.

scientific article published on 29 December 2015

ALK-dependent control of hypoxia-inducible factors mediates tumor growth and metastasis.

scientific article published on 5 September 2014

Angiogenesis in neuroblastoma.

scientific article

Anti-Tumor Effects of Bak-Proteoliposomes against Glioblastoma.

scientific article published on September 2015

Chromogranin A binds to αvβ6-integrin and promotes wound healing in mice

scientific article published on 14 March 2012

Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma

scientific article published on 24 March 2010

Combined therapeutic effects of vinblastine and rapamycin on human neuroblastoma growth, apoptosis, and angiogenesis

scientific article

Critical role of flanking residues in NGR-to-isoDGR transition and CD13/integrin receptor switching

scientific article published on 11 January 2010

Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects.

scientific article published on February 2000

Development of Fab' fragments of anti-GD(2) immunoliposomes entrapping doxorubicin for experimental therapy of human neuroblastoma.

scientific article

Discovery of a novel glucose metabolism in cancer: The role of endoplasmic reticulum beyond glycolysis and pentose phosphate shunt

scientific article published on 28 April 2016

Doxorubicin effect on myocardial metabolism as a pre-requisite for subsequent development of cardiac toxicity: a translational (18)F-FDG PET/CT observation.

scientific article published on 23 June 2017

Doxorubicin-loaded Fab' fragments of anti-disialoganglioside immunoliposomes selectively inhibit the growth and dissemination of human neuroblastoma in nude mice

scientific article published on 01 January 2003

Drug delivery systems: application of liposomal anti-tumor agents to neuroectodermal cancer treatment

scientific article published on 01 March 2008

Enhanced anti-tumor activity of a new curcumin-related compound against melanoma and neuroblastoma cells

scientific article

Enhanced antitumor efficacy of clinical-grade vasculature-targeted liposomal doxorubicin

scientific article

Enhancement of Tumor Homing by Chemotherapy-Loaded Nanoparticles

scientific article published on 07 October 2018

Extracts from Cell Suspension Cultures of Strawberry (Fragaria x ananassa Duch): Cytotoxic Effects on Human Cancer Cells

scientific article published on 04 May 2019

Frizzled receptor 6 marks rare, highly tumourigenic stem-like cells in mouse and human neuroblastomas.

scientific article published in December 2011

GD2-mediated melanoma cell targeting and cytotoxicity of liposome-entrapped fenretinide

Glycine N-methylation in NGR-Tagged Nanocarriers Prevents Isoaspartate formation and Integrin Binding without Impairing CD13 Recognition and Tumor Homing

scientific article published on September 2017

Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs.

scientific article published on August 2004

Immunoliposomal fenretinide: a novel antitumoral drug for human neuroblastoma.

scientific article

Immunotherapy in the Treatment of Human Solid Tumors: Basic and Translational Aspects.

scientific article published on June 2016

In vitro and in vivo antitumor activity of liposomal Fenretinide targeted to human neuroblastoma.

scientific article published in May 2003

In vivo angiogenic activity of neuroblastoma correlates withMYCN oncogene overexpression

scientific article published on 01 December 2002

Ligand-targeted liposomal therapies of neuroblastoma.

scientific article published on January 2007

Liposome-mediated therapy of neuroblastoma

scientific article published in January 2009

Microfragmented human fat tissue is a natural scaffold for drug delivery: Potential application in cancer chemotherapy

scientific article published on 16 March 2019

Molecular galactose-galectin association in neuroblastoma cells: An unconventional tool for qualitative/quantitative screening

scientific article

Nanocarrier-mediated targeting of tumor and tumor vascular cells improves uptake and penetration of drugs into neuroblastoma.

scientific article published on 05 August 2013

Neuroblastoma targeting by c-myb-selective antisense oligonucleotides entrapped in anti-GD2 immunoliposome: immune cell-mediated anti-tumor activities.

scientific article

Neuroblastoma tumorigenesis is regulated through the Nm23-H1/h-Prune C-terminal interaction

scientific article

Neuroblastoma-targeted nanocarriers improve drug delivery and penetration, delay tumor growth and abrogate metastatic diffusion

scientific article published on August 2015

New therapeutic strategies in neuroblastoma: combined targeting of a novel tyrosine kinase inhibitor and liposomal siRNAs against ALK.

scientific article published on 20 June 2015

Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings.

scientific article

Overcoming Biological Barriers in Neuroblastoma Therapy: The Vascular Targeting Approach with Liposomal Drug Nanocarriers

scientific article published on 01 February 2019

PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance

scientific article published on 15 July 2015

Potent and sustained inhibition of HIF-1α and downstream genes by a polyethyleneglycol-SN38 conjugate, EZN-2208, results in anti-angiogenic effects

scientific article

Preclinical evaluation of the first intravenous small molecule MDM2 antagonist alone and in combination with temozolomide in neuroblastoma

scientific article published on 09 January 2019

Selective therapeutic targeting of the anaplastic lymphoma kinase with liposomal siRNA induces apoptosis and inhibits angiogenesis in neuroblastoma

scientific article published on 9 August 2011

Spatiotemporal Regulation of Tumor Angiogenesis by Circulating Chromogranin A Cleavage and Neuropilin-1 Engagement

scientific article published on 22 February 2019

Special Issue "Recent Advances in Precision Nanomedicine for Cancer"

scientific article published on 10 September 2020

Spot overlapping in two-dimensional maps: a serious problem ignored for much too long

scientific article published in June 2005

Targeted delivery system for antisense oligonucleotides: a novel experimental strategy for neuroblastoma treatment.

scientific article

Targeted drug delivery and penetration into solid tumors

scientific article published on February 2011

Targeting Macrophages as a Potential Therapeutic Intervention: Impact on Inflammatory Diseases and Cancer

scientific article published in 2018

Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma

scientific article published on 15 October 2020

Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy

scientific article published on October 2006

The Neuronal Pentraxin-2 Pathway Is an Unrecognized Target in Human Neuroblastoma, Which Also Offers Prognostic Value in Patients.

scientific article published on 20 August 2015

The combined therapeutic effects of bortezomib and fenretinide on neuroblastoma cells involve endoplasmic reticulum stress response

scientific article

The use of the orthotopic model to validate antivascular therapies for cancer ⬇️

scientific article published on January 1, 2011

Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastoma

scientific article published on 29 May 2015

Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy

scientific article published on 01 November 2003

sTRAIL coupled to liposomes improves its pharmacokinetic profile and overcomes neuroblastoma tumour resistance in combination with Bortezomib

scientific article

Paulina is supported by:

About Paulina

Help